WashU startup Prognosia acquired by Lunit to advance AI-based breast cancer prediction

An innovative biotech startup founded by researchers at Washington University School of Medicine in St. Louis has been acquired by Lunit, a leading company in developing AI-based technologies for cancer prevention and early detection.